In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A Sea Change In Cardiac Imaging

Executive Summary

Interventional cardiology has been among the leading areas of medical device innovation. Yet despite the plethora of new products and procedures, a vital part of all these improvements--cardiac imaging--has largely remained unchanged over the past 40 years. Cardiac Mariners is developing a new x-ray system specifically designed to improve imaging and protect the safety of medical staff as well as patients. Even if its image quality is no better than conventional imaging methods, Cardiac Mariners' technology should have enormous appeal to interventional cardiologists because it addresses a problem these physicians have been reluctant to address: exposure to radiation.

You may also be interested in...



China Re-Infection Case Ignites Antibody Durability Debate

Amid a case of re-infection of a vaccinated healthcare worker in western China’s Xi’an city, and ongoing debate over domestic vaccines' efficacy, increasing attention is being paid in China to raising inoculation rates for COVID-19 and moving towards herd immunity.

Medtronic Addresses Diabetes Care Disparities With New Equity Initiatives

The company announced new research investments and partnerships with the American Diabetes Association and the T1D Exchange to address racial disparities in treatment of diabetes.

QUOTED. 19 April 2021. Jeff Shuren & William Maisel

Two top officials in the US FDA’s device center are warning of delays in the agency’s review of submissions for new products that aren’t directly tied to the coronavirus pandemic.

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

IV001137

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel